Home
>
National Drug Code (NDC)
>
Bravelle
Bravelle - 55566-8505-6 - (urofollitropin)
Drug Information of Bravelle
| Product NDC: | 55566-8505 |
| Proprietary Name: | Bravelle |
| Non Proprietary Name: | urofollitropin |
| Active Ingredient(s): | & nbsp; urofollitropin |
| Administration Route(s): | INTRAMUSCULAR |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Bravelle
| Product NDC: | 55566-8505 |
| Labeler Name: | Ferring Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021289 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20020506 |
Package Information of Bravelle
| Package NDC: | 55566-8505-6 |
| Package Description: | 1 CARTON in 1 CARTON (55566-8505-6) > 1 KIT in 1 CARTON (55566-8505-2) * 2 mL in 1 VIAL, SINGLE-USE * 2 mL in 1 VIAL, SINGLE-USE |
NDC Information of Bravelle
| NDC Code | 55566-8505-6 |
| Proprietary Name | Bravelle |
| Package Description | 1 CARTON in 1 CARTON (55566-8505-6) > 1 KIT in 1 CARTON (55566-8505-2) * 2 mL in 1 VIAL, SINGLE-USE * 2 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 55566-8505 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | urofollitropin |
| Dosage Form Name | KIT |
| Route Name | INTRAMUSCULAR |
| Start Marketing Date | 20020506 |
| Marketing Category Name | NDA |
| Labeler Name | Ferring Pharmaceuticals Inc. |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
